Lung Cancer Patient-Centered Outcomes and Survivorship Award
This grant funds research to improve health outcomes and patient experiences for lung cancer patients, requiring inclusion of a patient advocate and focusing on survivorship or health outcomes.
Funder: Dept. of the Army -- USAMRAA
Due Dates: August 18, 2026 (Pre-Application/LOI) | September 2, 2026 (Full Application) | September 4, 2026 (End of Application Verification)
Funding Amounts: Total program funding: $1,950,000; up to $975,000 total costs per award over 3 years; ~2 awards expected.
Summary: Supports research to improve patient-centered outcomes and survivorship in lung cancer, requiring inclusion of a lung cancer advocate on the team.
Key Information: Research must address at least one FY26 LCRP Health Outcomes & Survivorship area; animal studies and mesothelioma-only projects are not supported.
Description
This opportunity from the Dept. of the Army's USAMRAA (Congressionally Directed Medical Research Programs, CDMRP) aims to fund high-impact, evidence-based, and patient-centered research that improves health outcomes and survivorship for lung cancer patients. Projects must focus on at least one of the FY26 Lung Cancer Research Program (LCRP) areas of emphasis within the Health Outcomes and Survivorship category. A distinctive requirement is the inclusion of a lung cancer patient/survivor or caregiver advocate as an integral member of the research team. Both clinical and translational research, including pilot clinical trials, are supported, but animal studies and mesothelioma-only projects are not eligible.
